{"organizations": [], "uuid": "7e3e09dd54de330d09653d7c1b51c5cb801de478", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180220.html", "section_title": "Archive News &amp; Video for Tuesday, 20 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-fate-therapeutics-announces-first/brief-fate-therapeutics-announces-first-subject-treated-with-fate-nk100-in-dimension-study-for-advanced-solid-tumors-idUSFWN1QA0KK", "country": "US", "domain_rank": 408, "title": "BRIEF-Fate Therapeutics Announces First Subject Treated With Fate-NK100 In Dimension Study For Advanced Solid Tumors", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.733, "site_type": "news", "published": "2018-02-20T21:23:00.000+02:00", "replies_count": 0, "uuid": "7e3e09dd54de330d09653d7c1b51c5cb801de478"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-fate-therapeutics-announces-first/brief-fate-therapeutics-announces-first-subject-treated-with-fate-nk100-in-dimension-study-for-advanced-solid-tumors-idUSFWN1QA0KK", "ord_in_thread": 0, "title": "BRIEF-Fate Therapeutics Announces First Subject Treated With Fate-NK100 In Dimension Study For Advanced Solid Tumors", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "fate therapeutics inc", "sentiment": "negative"}, {"name": "advanced solid tumors feb", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 20 (Reuters) - Fate Therapeutics Inc:\n* FATE THERAPEUTICS ANNOUNCES FIRST SUBJECT TREATED WITH FATE-NK100 IN DIMENSION STUDY FOR ADVANCED SOLID TUMORS Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-20T21:23:00.000+02:00", "crawled": "2018-02-21T21:23:23.013+02:00", "highlightTitle": ""}